1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Adline Chem Lab Limited

Adline Chem Lab Limited

BBSE:ADLINE
15.79
INR
0.00
(0.00%)
Adline Chem Lab Limited
BSE:ADLINE
(Bombay Stock Exchange)

Recent

price

15.79

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Adline Chem Lab Ltd. operates as a diversified entity delivering integrated solutions across the chemical and pharmaceutical industries. The company specializes in marketing a broad portfolio of pharmaceutical formulations, including anti-infectives, multivitamins, and products for reproductive, liver, and pain management, with production handled by third-party manufacturers. Additionally, it provides fine chemicals, agrochemical products, biotechnology solutions, and laboratory equipment, alongside offering R&D and consultancy services to global clients. Established by Kamlesh J. Laskari on July 6, 1988, and headquartered in Ahmedabad, India, the firm saw recent leadership changes with Vrushank Patel appointed Chairman in November 2025.